Search research articles
Contact Us
Filters
Showing results (321-330 of 392) with videos related to
Page
of 40
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 31, 2019
Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC
Triparna Sen, Carminia M Della Corte, Snezana Milutinovic, et al.
JAMA Network Open
|
June 6, 2022
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab
Yufei Liu, Zhe Zhang, Waree Rinsurongkawong, et al.
Molecular Cancer Research : MCR
|
November 11, 2020
AXL Inhibition Induces DNA Damage and Replication Stress in Non-Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors
Kavya Ramkumar, C Allison Stewart, Kasey R Cargill, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)
|
May 28, 2013
ShearWave™ Elastography BE1 multinational breast study: additional SWE™ features support potential to downgrade BI-RADS®-3 lesions
F K W Schäfer, R J Hooley, R Ohlinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study
Lauren Averett Byers, Dmitry Bentsion, Steven Gans, et al.
Nature Communications
|
March 21, 2018
Wnt ligands influence tumour initiation by controlling the number of intestinal stem cells
D J Huels, L Bruens, M C Hodder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2021
Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
Ying Jin, Yamei Chen, Huarong Tang, et al.
European Urology Focus
|
June 1, 2019
Genomic Features of Metastatic Testicular Sex Cord Stromal Tumors
Andrea Necchi, Gennady Bratslavsky, Oleg Shapiro, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 29, 2022
Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial
Carminia Maria Della Corte, Morena Fasano, Vincenza Ciaramella, et al.
Urologic Oncology
|
March 29, 2021
Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinoma
Gennady Bratslavsky, Stephanie Gleicher, Joseph M Jacob, et al.
Page
of 40
Search research articles
Search
Showing results (321-330 of 392) with videos related to
Sort By:
Page
of 40
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 31, 2019
Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC
Triparna Sen, Carminia M Della Corte, Snezana Milutinovic, et al.
JAMA Network Open
|
June 6, 2022
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab
Yufei Liu, Zhe Zhang, Waree Rinsurongkawong, et al.
Molecular Cancer Research : MCR
|
November 11, 2020
AXL Inhibition Induces DNA Damage and Replication Stress in Non-Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors
Kavya Ramkumar, C Allison Stewart, Kasey R Cargill, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)
|
May 28, 2013
ShearWave™ Elastography BE1 multinational breast study: additional SWE™ features support potential to downgrade BI-RADS®-3 lesions
F K W Schäfer, R J Hooley, R Ohlinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study
Lauren Averett Byers, Dmitry Bentsion, Steven Gans, et al.
Nature Communications
|
March 21, 2018
Wnt ligands influence tumour initiation by controlling the number of intestinal stem cells
D J Huels, L Bruens, M C Hodder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2021
Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer
Ying Jin, Yamei Chen, Huarong Tang, et al.
European Urology Focus
|
June 1, 2019
Genomic Features of Metastatic Testicular Sex Cord Stromal Tumors
Andrea Necchi, Gennady Bratslavsky, Oleg Shapiro, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 29, 2022
Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial
Carminia Maria Della Corte, Morena Fasano, Vincenza Ciaramella, et al.
Urologic Oncology
|
March 29, 2021
Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinoma
Gennady Bratslavsky, Stephanie Gleicher, Joseph M Jacob, et al.
Page
of 40